EDGAR Filing Documents for 0001213900-19-027270

Form 1-A/A - Offering Statement [Regulation A]: [Amend]

SEC Accession No. 0001213900-19-027270

Filing Date

2019-12-31

Accepted

2019-12-31 14:42:50

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	1-A/A
1		primary_doc.xml	1-A/A	17922
2	AMENDMENT NO. 3 TO FORM 1-A	f1a2019a3_2020genesystems.htm	PART II AND III	1120933
3	POSTING AGREEMENT, DATED DECEMBER [*], 2019, BETWEEN 20/20 GENESYSTEMS, INC. AND	f1a2019a3ex1-1_2020gene.htm	EX1A-1 UNDR AGMT	218628
4	FORM OF SUBSCRIPTION AGREEMENT	f1a2019a3ex4-1_2020gene.htm	EX1A-4 SUBS AGMT	71186
5	CONSENT OF DBBMCKENNON	f1a2019a3ex11-1_2020gene.htm	EX1A-11 CONSENT	1808
6	GRAPHIC	image_001.jpg	GRAPHIC	546833
7	GRAPHIC	image_002.jpg	GRAPHIC	554984
8	GRAPHIC	image_003.jpg	GRAPHIC	45759
9	GRAPHIC	image_004.jpg	GRAPHIC	49590
10	GRAPHIC	image_005.jpg	GRAPHIC	42018
11	GRAPHIC	image_006.jpg	GRAPHIC	283817
12	GRAPHIC	image_007.jpg	GRAPHIC	57862
	Complete submission text file	0001213900-19-027270.txt		3604232

Mailing Address 9430 KEY WEST AVE. ROCKVILLE MD 20850

Business Address 9430 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 2404536339

20/20 GeneSystems, Inc. (Filer) CIK: 0001139685 (see all company filings)